Clinical Trials for Aju Pharm

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Aju Pharm

Clinical Trials (6)

NCT07034781
A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults
PHASE1Not yet recruiting
50 participants
Started: Aug 31, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT07044765
A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study
PHASE1Not yet recruiting
32 participants
Started: Aug 31, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06933459
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults
PHASE1Active, not recruiting
60 participants
Started: May 24, 2025 · Completed: Jun 24, 2025
1 condition1 sponsor1 location
NCT06345014
The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome
PHASE4Recruiting
332 participants
Started: Dec 20, 2023 · Completed: Mar 30, 2026
3 conditions2 sponsors1 location
NCT06291194
Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients
PHASE3Recruiting
396 participants
Started: Nov 10, 2023 · Completed: May 31, 2024
1 condition2 sponsors1 location
NCT06416865
Efficacy and Safety of AJU-C52 in Essential Hypertension Patients
PHASE3Recruiting
190 participants
Started: Jun 27, 2022 · Completed: Aug 31, 2024
1 condition1 sponsor1 location